Abstract:Objective To evaluate the clinical effect of post bladder sparing surgery intra-arterial chemotherapy combined with intravesical chemotherapy for the treatment of T1G3 bladder urothelial carcinoma. Methods Seventy-four T1G3 bladder cancer patients were enrolled in this study.After bladder sparing surgery,22 patients received intra-arterial chemotherapy combined with intravesical chemotherapy,while the other 52 patients were treated with intravesical chemotherapy only.There was no significant difference between the 2 groups in sex,age,the size and number of bladder tumor and newly diagnosed cases (P ＞0.05).Twenty-two patients were treated with intra-arterial chemotherapy of piarubicin or epirubicin (40 -60 mg) + cisplatin (60 -80 mg) 2 or 3 weeks after bladder sparing surgery,3 times as a cycle,repeat every 4 - 6 weeks.All the patients received the same protocol of intravesical chemotherapy.With a median follow-up of 32 months,effects of combination therapy group were compared with intravesical chemotherapy group in the aspects of tumor-specific death rates,recurrent rate,progressive rate,recurrent interval and the adverse reactions. Results The tumor-specific death rates of combination therapy group and intravesical chemotherapy group were 0％ (0/22) and 13.5％ (7/52),respectively.There was no difference between the 2 groups (P =0.096).The recurrent rates were 13.6％ (3/22) and 46.2％ ( 24/52 ) ； The progressive rates were 0％ (0/22) and 21.2％ (11/52).There were significant differences between the 2 groups in recurrent rate (P =0.000) and progressive rate (P =0.048 ).The recurrent intervals of the 2 groups were 15 months and 6.5 months.During the interval of intra-arterial chemotherapy cycle,12 patients suffered 1 -2 degree nausea and vomit,2 patients suffered hypoleukemia,2 patients suffered neutropenia,4 patients'liver function was impaired and 1 patient's renal function was impaired.All the adverse reactions were minimal and reversible. Conclusions Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing T1 G3 bladder cancer from recurrence and metastasis after bladder sparing surgery.The adverse reactions of this protocol were minimal and reversible.

Bladder Preservation by Internal Iliac Arterial Infusion Chemotherapy and Radiotherapy in Invasive Bladder Carcinoma

Combined Modality Therapy Following Bladder Conservation Surgery for Bladder Cancers

The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer

Combinations of Internal lliac Arterial Chemotherapy and Bladderpreserving Resection for Local Invasive Bladder Cancer

Intra-arterial Chemotherapy for Preventing the Recurrence of Invasive Bladder Cancer after Operation

Postoperative Radiotherapy Combined with Cisplatin Intravesical Infusion to Prevent Relapse in Invasive Bladder Cancer

The clinical study of intra-arterial chemotherapy followed by bladder-preserving surgery for high-risk non muscle-invasive bladder cancer

Effect of Post Bladder Sparing Operation Intra-Arterial Chemotherapy Combined with Intravesical Chemotheraoy for the Treatment of T1G3 Bladder Urothelial Carcinoma

Intra-Arterial Chemotherapy for Muscle-Invasive Bladder Cancer Following Transurethral Resection

Bladder preservation and intravesical therapy for bladder cancer

Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.

Preoperative Selective Internal Iliac Arterial Chemotherapy for Invasive Bladder Cancer

Combinations of neoadjuvant chemotherapy and transurethral resection for invasive bladder cancer

Clinical effect of iliac artery interventional chemotherapy combination with bladder perfusion for high level of bladder urothelial carcinoma

Internal iliac artery chemoembolization combined with transurethral electrocoagulation resection for advanced bladder cancer: preliminary results in 17 cases

Radiotherapy in the Patients with Bladder Carcinoma Treated by Conservative Surgery

A Role of Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer Plus Hydronephrosis with or Without Pelvic Nodal Involvement.

Single-dose intra-arterial infusion chemotherapy for refractory bladder cancer after transurethral resection of bladder tumor: Report of 12 cases

Initial Results of Intra-arterial Chemotherapy for Poorly Differentiated Bladder Transitional Cell Carcinoma

The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer

Combinations of Intra-Artery Chemotherapy and Bladder-Preserving Resection for Primary T1G3 Bladder Cancer